Year |
Citation |
Score |
2022 |
Struczyńska M, Firkowska-Boden I, Scheuer K, Jandt KD. Rutile facet-dependent fibrinogen conformation: Why crystallographic orientation matters. Colloids and Surfaces. B, Biointerfaces. 215: 112506. PMID 35487071 DOI: 10.1016/j.colsurfb.2022.112506 |
0.557 |
|
2022 |
Czapka A, Grune C, Schädel P, Bachmann V, Scheuer K, Dirauf M, Weber C, Skaltsounis AL, Jandt KD, Schubert US, Fischer D, Werz O. Drug delivery of 6-bromoindirubin-3'-glycerol-oxime ether employing poly(D,L-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents. Journal of Nanobiotechnology. 20: 5. PMID 34983538 DOI: 10.1186/s12951-021-01179-7 |
0.466 |
|
2021 |
Scheuer K, Helbing C, Firkowska-Boden I, Jandt KD. Self-assembled fibrinogen-fibronectin hybrid protein nanofibers with medium-sensitive stability. Rsc Advances. 11: 14113-14120. PMID 35423936 DOI: 10.1039/d0ra10749b |
0.484 |
|
2021 |
Pusch L, Brox R, Scheuer K, Yokosawa T, Wu M, Zubiri BA, Spiecker E, Jandt KD, Fischer D, Hackstein H. Distinct endocytosis and immune activation of poly lactic-co-glycolic acid nanoparticles prepared by single- and double-emulsion evaporation. Nanomedicine (London, England). PMID 34523349 DOI: 10.2217/nnm-2021-0022 |
0.487 |
|
2021 |
Grune C, Zens C, Czapka A, Scheuer K, Thamm J, Hoeppener S, Jandt KD, Werz O, Neugebauer U, Fischer D. Sustainable preparation of anti-inflammatory atorvastatin PLGA nanoparticles. International Journal of Pharmaceutics. 120404. PMID 33647413 DOI: 10.1016/j.ijpharm.2021.120404 |
0.475 |
|
2020 |
Bandelli D, Muljajew I, Scheuer K, Max JB, Weber C, Schacher FH, Jandt KD, Schubert US. Copolymerization of Caprolactone Isomers to Obtain Nanoparticles with Constant Hydrophobicity and Tunable Crystallinity Macromolecules. 53: 5208-5217. DOI: 10.1021/Acs.Macromol.0C00486 |
0.529 |
|
Show low-probability matches. |